PHARMacist tool for Achieving A1C Targets with Fixed Ratio Combination Therapy (PHARM A1C-Fix)
Fixed Ratio Combinations (FRC) of basal insulin and GLP-1 receptor agonists (GLP-1 RA) provide patients with type 2 diabetes a combination of two injectable antihyperglycemic agents with complementary mechanisms of action in a single injection. The use of FRC has been shown to be more effective than either component alone with a lower risk of adverse effects for both basal insulin and GLP-1 RA.
Alexander Abitbol, MDCM, FRCPC Ronald M. Goldenberg, MD, FRCPC, FACE Alicia Chin, RPh Carlene Oleksyn, B.S.P. Pharm, CTH™